Glucagon
Brand names: GlucaGen, Baqsimi (nasal powder)
A pancreatic hormone given parenterally as emergency treatment for severe hypoglycaemia, and also used to relax smooth muscle for certain radiological procedures.
Adult dose
Dose adjustments
Can be used in patients with renal and hepatic impairment (no dose adjustment stated).
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to glucagon or to any of the excipients
- Phaeochromocytoma
Side effects
- Nausea
- Vomiting
- Abdominal pain
- Hypersensitivity reactions including anaphylactic reaction/shock (very rare)
- Injection site reactions
Interactions
- Insulin — acts antagonistically to glucagon
- Indomethacin — glucagon may lose its ability to raise blood glucose, or may produce hypoglycaemia
- Warfarin — glucagon may increase the anticoagulant effect
- Beta-blockers — transient increase in pulse and blood pressure
Clinical monograph
How it works
Glucagon stimulates hepatic glycogenolysis and gluconeogenesis to raise blood glucose, an effect that depends on adequate hepatic glycogen stores.
Prescribing in practice
- The most important safety point is that glucagon is ineffective when hepatic glycogen is depleted (for example in starvation, prolonged hypoglycaemia, chronic alcohol use, or adrenal insufficiency), so oral or intravenous glucose must follow once the patient can swallow or access allows.
- After recovery, give oral carbohydrate to replenish glycogen and prevent recurrent hypoglycaemia.
- Use with caution in phaeochromocytoma, insulinoma, and glucagonoma.
Monitoring
Monitor blood glucose and conscious level after administration, ensuring the patient eats carbohydrate once able and is observed for recurrence.
Counselling the patient
- Family or carers should be trained to recognise severe hypoglycaemia and to give the injection.
- After it works, eat a carbohydrate snack as soon as you can swallow safely.
- Always seek follow-up, as nausea and vomiting are common afterwards and low glucose can recur.
Evidence & guidelines
Glucagon is recommended for out-of-hospital treatment of severe hypoglycaemia in people with diabetes by NICE and national diabetes guidance.
Reference: JBDS Hypoglycaemia Guidelines 2018; NICE NG17; Baqsimi SPC (Eli Lilly); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Glucose Infusion Rate (GIR) Calculator · Glucose Management
- Burch-Wartofsky Score (Thyroid Storm) · Thyroid Crisis
- Hypoglycaemia Severity Classification · Diabetes Management
- Lund-Mackay CT Score for Chronic Rhinosinusitis · Sinonasal
- SNOT-22 (Sinonasal Outcome Test) · Chronic Rhinosinusitis
- Epistaxis Severity Score (ESS) · Epistaxis